Irbesartan/Hydrochlorothiazide Sandoz

Irbesartan, the active ingredient in Irbesartan/Hydrochlorothiazide Sandoz, is an angiotensin II receptor blocker presented as an oral tablet formulation for oral use. It is combined with hydrochlorothiazide to treat hypertension in adult patients requiring dual therapy.

GNH USA supplies Irbesartan/Hydrochlorothiazide Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality, reliable logistics and documentation support across global markets.

Irbesartan/Hydrochlorothiazide is indicated for the management of hypertension, a condition characterized by elevated arterial blood pressure. - Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension. - Essential hypertension: provides combined vasodilatory and diuretic effects to achieve target blood pressure. - Hypertension with fluid retention: helps control blood pressure when monotherapy is insufficient.

Irbesartan/Hydrochlorothiazide may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Dizziness: light‑headed sensation, especially after standing. - Increased urination: due to the diuretic component. - Electrolyte imbalance: mild reductions in potassium or sodium. - Headache: transient head discomfort.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing faintness. - Angioedema: swelling of face, lips, tongue or throat. - Renal impairment: worsening kidney function. - Hyperkalemia: elevated potassium levels that may affect heart rhythm.

Before initiating therapy, consider the following precautions. - Blood pressure monitoring: check regularly to avoid excessive lowering. - Electrolyte assessment: monitor potassium and sodium levels during treatment. - Renal function: evaluate creatinine and eGFR before and throughout therapy. - Pregnancy: avoid unless clearly needed and discussed with a physician. - Drug interactions: review concomitant medications for potential risks. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Irbesartan/Hydrochlorothiazide can interact with other medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. - Aliskiren in diabetic patients: increased renal adverse events. - Lithium: heightened lithium toxicity. - ACE inhibitors or ARBs combined with NSAIDs: possible renal function decline.

Moderate Interactions (Monitor Closely): - Additional antihypertensives: additive blood‑pressure lowering effect. - CYP2C9 inhibitors (e.g., fluconazole): may raise irbesartan concentrations. - Non‑steroidal anti‑inflammatory drugs: may reduce diuretic efficacy.